Expression, regulation and function of carrier proteins for cationic amino acids

Current Opinion in Nephrology and Hypertension

Volumn 11, Issue 1, 2002, Pages 99-107

  Closs, Ellen Ildicho ^a  

^a Department of Pharmacology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CARRIER PROTEIN; CATION;

AMINO ACID TRANSPORT; ENDOTHELIUM CELL; ENZYME SUBSTRATE; HUMAN; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; REVIEW;

AMINO ACID TRANSPORT SYSTEM Y+; AMINO ACID TRANSPORT SYSTEMS, BASIC; ANIMALS; HUMANS; SODIUM;

EID: 0036140958     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200201000-00015     Document Type: Review

References (83)

1. Transporters for cationic amino acids in animal cells: Discovery, structure, and function
2. Membrane transport of L-arginine and cationic amino acids analogs
3. Relationship between arginase activity and nitric oxide production
4. Regulation of arginine availability and its impact on NO synthesis
5. Arginine metabolism and the synthesis of nitric oxide in the nervous system
6. The transport of cationic amino acids across the plasma membrane of mammalian cells
7. Cationic amino acid transporters (CATs) - Targets for the manipulation of NO synthase activity?
8. Human cationic amino acid transporters hCAT-1, hCAT-2A, and hCAT-2B: Three related carriers with distinct transport properties
9. Human cationic amino acid transporter hCAT-3 is preferentially expressed in peripheral tissues
10. Cloning and characterization of a brain-specific cationic amino acid transporter
11. A new member of the cationic amino acid transporter family is preferentially expressed in adult mouse brain
12. Voltage dependence of L-arginine transport by hCAT-2A and hCAT-2B expressed in oocytes from Xenopus laevis
13. The gene encoding a cationic amino acid transporter (SLC7A4) maps to the region deleted in the velocardiofacial syndrome
14. Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: Role of cationic amino acid transporters
15. Regulation of CAT: Cationic amino acid transporter gene expression
16. L-arginine transport is increased in macrophages generating nitric oxide
17. Characterization of the third member of the MCAT family of cationic amino acid transporters - Identification of a domain that determines the transport properties of the MCAT proteins
18. Co-induction of argininosuccinate synthetase, cationic amino acid transporter-2, and nitric oxide synthase in activated murine microglial cells
19. Induced nitric oxide synthesis is dependent on induced alternatively spliced CAT-2 encoding L-arginine transport in brain astrocytes
20. Nuclear factor-κB mediates simultaneous induction of inducible nitric-oxide synthase and up-regulation of the cationic amino acid transporter CAT-2B in rat alveolar macrophages
21. Transmembrane signalling mechanisms regulating expression of cationic amino acid transporters and inducible nitric oxide synthase in rat vascular smooth muscle cells
22. Cationic amino acid transporter gene expression in cultured vascular smooth muscle cells and in rats
23. Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure
24. Increased L-arginine uptake and inducible nitric oxide synthase activity in aortas of rats with heart failure
25. Effects of Mycobacterium bovis BCG infection on regulation of L-arginine uptake and synthesis of reactive nitrogen intermediates in J774.1 murine macrophages
26. Apolipoprotein E acts to increase nitric oxide production in macrophages by stimulating arginine transport
27. Tetrahydrobiopterin augments arginine transport in rat cardiac myocytes through modulation of CAT-2 mRNA
28. Induction of L-arginine transport is inhibited by atrial natriuretic peptide: A peptide hormone as a novel regulator of inducible nitric-oxide synthase substrate availability
29. Concomitant down-regulation of L-arginine transport and nitric oxide (NO) synthesis in rat alveolar macrophages by the polyamine spermine
30. Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport
31. Selective inhibition by dexamethasone of induction of NO synthase, but not of induction of L-arginine transport, in activated murine macrophage J774 cells
32. Stimulation of arginine transport and nitric oxide production by lipopolysaccharide is mediated by different signaling pathways in astrocytes
33. Induction of L-arginine transport and nitric oxide synthase in vascular smooth muscle cells: Synergistic actions of proinflammatory cytokines and bacterial lipopolysaccharide
34. CAT2-mediated L-arginine transport and nitric oxide production in activated macrophages
35. Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-arginine transport and no production by CAT-1, CAT-2A, and CAT-2B
36. The transport activity of the human cationic amino acid transporter hCAT-1 is downregulated by activation of protein kinase C
37. Association of L-arginine transporters with fodrin: Implications for hypoxic inhibition of arginine uptake
38. Cationic amino acid transporter-2 mRNA induction by tumor necrosis factor-alpha in vascular endothelial cells
39. In vivo and in vitro evidence for impaired arginine transport in human heart failure
40. L-arginine uptake, the citrulline-NO cycle and arginase II in the rat brain: An in situ hybridization study
41. Differential expression of the cationic amino acid transporter 2(B) in the adult rat brain
42. Neuron-specific expression of cationic amino acid transporter 3 in the adult rat brain
43. Characterization of L-arginine transporters in rat renal inner medullary collecting duct
44. Physiological cyclic stretch directs L-arginine transport and metabolism to collagen synthesis in vascular smooth muscle
45. Transforming growth factor-beta(1) stimulates L-arginine transport and metabolism in vascular smooth muscle cells: Role in polyamine and collagen synthesis
46. Effects of dietary salt intake on plasma arginine
47. Molecular sites of regulation of expression of the rat cationic amino acid transporter gene
48. Post-transcriptional regulation of the arginine transporter Cat-1 by amino acid availability
49. Adaptive regulation of the cationic amino acid transporter-1 (Cat-1) in Fao cells
50. Internal ribosome entry site-mediated translation of a mammalian mRNA is regulated by amino acid availability
51. TA1/LAT-1/CD98 light chain and system L activity, but not 4F2/CD98 heavy chain, respond to arginine availability in rat hepatic cells. Loss of response in tumor cells
52. Cytoskeletal regulation of the L-arginine/NO pathway in pulmonary artery endothelial cells
53. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the 'arginine paradox'
54. Coinduction of inducible nitric oxide synthase and arginine recycling enzymes in cytokine-stimulated PC12 cells and high output production of nitric oxide
55. Expression of citrulline-nitric oxide cycle in lipopolysaccharide and cytokine-stimulated rat astroglioma C6 cells
56. Sustained nitric oxide production in macrophages requires the arginine transporter CAT2
57. Inhibition of nitric oxide synthase abrogates lipopolysaccharides-induced up-regulation of L-arginine uptake in rat alveolar macrophages
58. Induction of argininosuccinate synthetase in rat brain glial cells after striatal microinjecfion of immunostimulants
59. Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases
60. Essential role of L-arginine uptake and protein tyrosine kinase activity for NO-dependent vasorelaxation induced by stretch, isometric tension and cyclic AMP in rat pulmonary arteries
61. Critical dependence of the NO-mediated component of cyclic AMP-induced vasorelaxation on extracellular L-arginine in pulmonary arteries of the rat
62. The molecular basis of cystinuria: An update
63. Heteromeric amino acid transporters explain inherited aminoacidurias
64. The molecular bases of cystinuria and lysinuric protein intolerance
65. 0,+ and cystinuria
66. Glycoprotein-associated amino acid exchangers: Broadening the range of transport specificity
67. +L) in human erythrocytes that recognizes lysine and leucine with high affinity
68. SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance
69. +L - A candidate gene for lysinuric protein intolerance
70. +L in cultured human fibroblasts: Normal phenotype of cells from lysinuric protein intolerance subjects
71. +L in erythrocytes of patients with lysinuric protein intolerance
72. +LAT2 mediates arginine efflux in exchange with glutamine
73. +L as the high-affinity transporter for L-arginine in human platelets: Up-regulation of L-arginine influx in uraemia
74. +-independent transport of basic and zwitterionic amino acids in mouse blastocysts by a shared system and by processes which distinguish between these substrates
75. Molecular biology of mammalian plasma membrane amino acid transporters
76. +-dependent transport of basic, zwitterionic, and bicyclic amino acids by a broad scope system in mouse blastocytes
77. 0,+
78. 0,+
79. Functional changes in cation-preferring amino acid transport during development of preimplantation mouse conceptuses
80. A novel human amino acid transporter, hNAT3: cDNA cloning, chromosomal mapping, genomic structure, expression, and functional characterization
81. Evidence for the transport of neutral as well as cationic amino acids by ATA3, a novel and liver-specific subtype of amino acid transport system A
82. 0,+
83. Carboxypeptidase D is up-regulated in RAW264.7 macrophages and stimulates nitric oxide synthesis by cells in arginine-free medium